Stock Research: Granules India

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Granules India

NSI:GRANULES INE101D01020
53
  • Value
    41
  • Growth
    65
  • Safety
    Safety
    29
  • Combined
    42
  • Sentiment
    64
  • 360° View
    360° View
    53
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Granules India Limited is an India-based pharmaceutical manufacturing company. It operates in pharmaceutical products, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs), and finished dosages, and owns Senn Chemicals AG, a CDMO specializing in peptide development and manufacturing. The company sells its products in global markets, including India, the United States of America, Canada, Latin America, Europe, and Asia Pacific. In the last fiscal year, the company had a market cap of $1410 million, profits of $323 million, and revenue of $524 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
41 47 65 73
Growth
65 73 69 23
Safety
Safety
29 15 31 47
Sentiment
64 77 67 4
360° View
360° View
53 59 72 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
73 95 95 20
Opinions Change
50 72 11 50
Pro Holdings
n/a 70 67 42
Market Pulse
38 22 46 29
Sentiment
64 77 67 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
41 47 65 73
Growth
65 73 69 23
Safety Safety
29 15 31 47
Combined
42 33 63 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
55 60 82 78
Price vs. Earnings (P/E)
63 62 86 74
Price vs. Book (P/B)
40 53 73 67
Dividend Yield
22 12 10 36
Value
41 47 65 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
86 80 72 72
Profit Growth
68 69 32 8
Capital Growth
21 27 80 45
Stock Returns
49 79 55 27
Growth
65 73 69 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
36 30 32 36
Refinancing
39 36 46 58
Liquidity
47 32 48 55
Safety Safety
29 15 31 47

Similar Stocks

Discover high‑ranked alternatives to Granules India and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Medium
Full Stock Analysis

Canara Bank

NSI:CANBK
Country: India
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Oil and Natural Gas

NSI:ONGC
Country: India
Industry: Oil & Gas Integrated
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: